Pathogenesis of Pandemic Influenza A (H1N1) and Triple-Reassortant Swine Influenza A (H1) Viruses in Mice

ABSTRACT The pandemic H1N1 virus of 2009 (2009 H1N1) continues to cause illness worldwide, primarily in younger age groups. To better understand the pathogenesis of these viruses in mammals, we used a mouse model to evaluate the relative virulence of selected 2009 H1N1 viruses and compared them to a representative human triple-reassortant swine influenza virus that has circulated in pigs in the United States for over a decade preceding the current pandemic. Additional comparisons were made with the reconstructed 1918 virus, a 1976 H1N1 swine influenza virus, and a highly pathogenic H5N1 virus. Mice were inoculated intranasally with each virus and monitored for morbidity, mortality, viral replication, hemostatic parameters, cytokine production, and lung histology. All 2009 H1N1 viruses replicated efficiently in the lungs of mice and possessed a high degree of infectivity but did not cause lethal disease or exhibit extrapulmonary virus spread. Transient weight loss, lymphopenia, and proinflammatory cytokine and chemokine production were present following 2009 H1N1 virus infection, but these levels were generally muted compared with a triple-reassortant swine virus and the 1918 virus. 2009 H1N1 viruses isolated from fatal cases did not demonstrate enhanced virulence in this model compared with isolates from mild human cases. Histologically, infection with the 2009 viruses resulted in lesions in the lung varying from mild to moderate bronchiolitis with occasional necrosis of bronchiolar epithelium and mild to moderate peribronchiolar alveolitis. Taken together, these studies demonstrate that the 2009 H1N1 viruses exhibited mild to moderate virulence in mice compared with highly pathogenic viruses.

[1]  Libo Dong,et al.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.

[2]  L. Finelli,et al.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.

[3]  P. Österlund,et al.  Pandemic H1N1 2009 Influenza A Virus Induces Weak Cytokine Responses in Human Macrophages and Dendritic Cells and Is Highly Sensitive to the Antiviral Actions of Interferons , 2009, Journal of Virology.

[4]  J. Taubenberger,et al.  An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. , 2009, Virology.

[5]  M. Álvarez-Lobos,et al.  Gastrointestinal manifestations among Chilean patients infected with novel influenza A (H1N1) 2009 virus , 2009, Gut.

[6]  Y. Shu,et al.  Clinical and Epidemiologic Characteristics of 3 Early Cases of Influenza A Pandemic (H1N1) 2009 Virus Infection, People’s Republic of China, 2009 , 2009, Emerging infectious diseases.

[7]  Hideo Goto,et al.  In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses , 2009, Nature.

[8]  Marion Koopmans,et al.  Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets , 2009, Science.

[9]  Ron A M Fouchier,et al.  Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.

[10]  Rahul Raman,et al.  Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice , 2009, Science.

[11]  T. Tumpey,et al.  Ocular Infection of Mice with Influenza A (H7) Viruses: a Site of Primary Replication and Spread to the Respiratory Tract , 2009, Journal of Virology.

[12]  Hui Zeng,et al.  Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response , 2008, Immunological reviews.

[13]  James E. Crowe,et al.  Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors , 2008, Nature.

[14]  K. Dimock,et al.  Sialic acid tissue distribution and influenza virus tropism , 2008, Influenza and other respiratory viruses.

[15]  Lucy A. Perrone,et al.  H5N1 and 1918 Pandemic Influenza Virus Infection Results in Early and Excessive Infiltration of Macrophages and Neutrophils in the Lungs of Mice , 2008, PLoS pathogens.

[16]  Lucy A. Perrone,et al.  Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus , 2008, Proceedings of the National Academy of Sciences.

[17]  V. Wiwanitkit Hemostatic disorders in bird flu infection , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[18]  Kelli L Boyd,et al.  Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. , 2007, Cell host & microbe.

[19]  A. Cupo,et al.  A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1). , 2007, Viral immunology.

[20]  T. Tumpey,et al.  Highly Pathogenic Avian Influenza H5N1 Viruses Elicit an Attenuated Type I Interferon Response in Polarized Human Bronchial Epithelial Cells , 2007, Journal of Virology.

[21]  Derek A T Cummings,et al.  Transmissibility of swine flu at Fort Dix, 1976 , 2007, Journal of The Royal Society Interface.

[22]  T. Tumpey,et al.  Pathogenesis of Avian Influenza (H7) Virus Infection in Mice and Ferrets: Enhanced Virulence of Eurasian H7N7 Viruses Isolated from Humans , 2007, Journal of Virology.

[23]  P. Palese,et al.  Influenza A Virus PB1-F2 Protein Contributes to Viral Pathogenesis in Mice , 2006, Journal of Virology.

[24]  J. Gaydos,et al.  Swine Influenza A Outbreak, Fort Dix, New Jersey, 1976 , 2006, Emerging infectious diseases.

[25]  Y. Guan,et al.  Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells , 2005, Respiratory research.

[26]  David E. Swayne,et al.  Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus , 2005, Science.

[27]  V. Wiwanitkit Anemia in the recent reported cases of bird flu infection in Thailand and Vietnam. , 2005, The Journal of infection.

[28]  J. Turnidge,et al.  Infectious complications of traditional Samoan tattooing. , 2005, The Journal of infection.

[29]  N. Cox,et al.  Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals , 2005, Journal of Virology.

[30]  Hidekazu Nishimura,et al.  Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus , 2004, Nature.

[31]  Constance Schultsz,et al.  Avian influenza A (H5N1) in 10 patients in Vietnam. , 2004, The New England journal of medicine.

[32]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[33]  J. M. González,et al.  A fluorimetric method for the estimation of G+C mol% content in microorganisms by thermal denaturation temperature. , 2002, Environmental microbiology.

[34]  Yoshihiro Kawaoka,et al.  Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses , 2001, Science.

[35]  T. Tumpey,et al.  Depletion of Lymphocytes and Diminished Cytokine Production in Mice Infected with a Highly Virulent Influenza A (H5N1) Virus Isolated from Humans , 2000, Journal of Virology.

[36]  Y. Guan,et al.  Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. , 2000, Virology.

[37]  N. Cox,et al.  A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans , 1999, Journal of Virology.

[38]  H. Goto,et al.  Biological Heterogeneity, Including Systemic Replication in Mice, of H5N1 Influenza A Virus Isolates from Humans in Hong Kong , 1999, Journal of Virology.

[39]  I. Mori,et al.  In vivo induction of apoptosis by influenza virus. , 1995, The Journal of general virology.

[40]  B. Murphy,et al.  A single amino acid in the PB2 gene of influenza A virus is a determinant of host range , 1993, Journal of virology.

[41]  G. Trinchieri,et al.  Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. , 1992, Journal of immunology.

[42]  C. E. Hoffmann,et al.  Sensitivity of influenza A/New Jersey/8/76 (Hsw1N1) virus to amantadine-HCl. , 1977, The Journal of infectious diseases.

[43]  F. Ennis,et al.  Serological responses to whole and split A/New Jersey vaccines in humans and mice following priming infection with influenza A viruses. , 1977, Developments in biological standardization.

[44]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[45]  N. Khardori,et al.  Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009 , 2009 .

[46]  Wang Guansong,et al.  Update on avian influenza A (H5N1) virus infection in humans , 2009 .

[47]  F. Dix Swine Influenza A Outbreak , 2006 .

[48]  T. A. Hall,et al.  BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .

[49]  S. Sanford,et al.  Swine influenza outbreak. , 1989 .